Andrew G. Reaume,Michael S. Saporito,Alexander R. Ochman
申请号：
US16546595
公开号：
US20200215067A1
申请日:
2019.08.21
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising the compounds or a pharmaceutically acceptable salts thereof that are useful in methods of preventing pancreatic beta cell degeneration or methods of treating a disorder associated with pancreatic beta cell degeneration, such as type I diabetes.
